Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor

American Journal of Physiology. Endocrinology and Metabolism
Wei GuMurielle M Véniant

Abstract

Antagonism of the glucagon receptor (GCGR) is associated with increased circulating levels of glucagon-like peptide-1 (GLP-1). To investigate the contribution of GLP-1 to the antidiabetic actions of GCGR antagonism, we administered an anti-GCGR monoclonal antibody (mAb B) to wild-type mice and GLP-1 receptor knockout (GLP-1R KO) mice. Treatment of wild-type mice with mAb B lowered fasting blood glucose, improved glucose tolerance, and enhanced glucose-stimulated insulin secretion during an intraperitoneal glucose tolerance test (ipGTT). In contrast, treatment of GLP-1R KO mice with mAb B had little efficacy during an ipGTT. Furthermore, pretreatment with the GLP-1R antagonist exendin-(9-39) diminished the antihyperglycemic effects of mAb B in wild-type mice. To determine the mechanism whereby mAb B improves glucose tolerance, we generated a monoclonal antibody that specifically antagonizes the human GLP-1R. Using a human islet transplanted mouse model, we demonstrated that pancreatic islet GLP-1R signaling is required for the full efficacy of the GCGR antagonist. To identify the source of the elevated GLP-1 observed in GCGR mAb-treated mice, we measured active GLP-1 content in pancreas and intestine from db/db mice treated with...Continue Reading

References

Oct 1, 1985·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·I M VarndellJ M Polak
Jul 16, 1970·The New England Journal of Medicine·W A MüllerR H Unger
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
Apr 5, 2000·The Journal of Clinical Investigation·Y NieT C Friedman
Feb 13, 2001·Endocrinology·D J Drucker
Jan 12, 2002·Biochemical and Biophysical Research Communications·Janice C ParkerJohn D McNeish
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·R W GellingM J Charron
Mar 11, 2003·American Journal of Physiology. Endocrinology and Metabolism·Guoqiang Jiang, Bei B Zhang
May 30, 2003·American Journal of Physiology. Endocrinology and Metabolism·Ronald L PrigeonDavid A D'Alessio
Jan 19, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·A Vella, R A Rizza
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Jan 9, 2009·The Journal of Pharmacology and Experimental Therapeutics·Hai YanMurielle M Véniant

❮ Previous
Next ❯

Citations

Aug 17, 2011·Diabetes, Obesity & Metabolism·Y Hayashi
Feb 13, 2015·Proceedings of the National Academy of Sciences of the United States of America·May-Yun WangRoger H Unger
Dec 25, 2012·Trends in Endocrinology and Metabolism : TEM·Joel F Habener, Violeta Stanojevic
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Jun 12, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·T MeraY Yasunami
Apr 9, 2015·Nature Reviews. Endocrinology·Jonathan E Campbell, Daniel J Drucker
Aug 1, 2012·Islets·Joel F Habener, Violeta Stanojevic
Jan 29, 2011·Diabetes·Dale S Edgerton, Alan D Cherrington
Mar 23, 2017·Endocrinology·Jens Juul HolstPedro L Herrera
Mar 10, 2017·Physiological Reviews·T D MüllerM H Tschöp
Feb 18, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Nam Q NguyenMichael Horowitz
Mar 13, 2012·Pharmacological Reviews·E J Verspohl
Apr 3, 2015·Physiological Reviews·Darleen A Sandoval, David A D'Alessio
Jan 26, 2020·International Journal of Molecular Sciences·Qi KangMingyu Li
Jul 25, 2019·JCI Insight·Megan E CapozziJonathan E Campbell
Jun 23, 2016·Diabetes Care·Mackenzie J PearsonWilliam L Holland
Sep 24, 2020·Endocrinology·Kimberley ElJonathan E Campbell
Jun 11, 2021·Frontiers in Endocrinology·Jenna Elizabeth HuntHannelouise Kissow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.